13 December: Collaborative Drug Discovery (CDD) will host a webinar discussing an innovative collaboration in the discovery and development of drugs to treat Tuberculosis

Missed the National AMR Forum? Read a recap of the Forum and CO-ADD's Drug Discovery & Development Workshop below.

It's World Antibiotic Awareness Week 2017. Bill Condie explores alternatives to antibiotic use to treat bacterial infections. 

Missed the 'Getting Through the Discovery Wall' antibiotic discovery webinar? Slides and videos from the webinar are now available.

Join CO-ADD on Thursday 2 November for a workshop on the ins and outs of drug discovery and development, part of the National AMR Forum to be held in Brisbane, Australia

20 September: CO-ADD's Dr Johannes Zuegg, joins other experts in a live webinar discussing the hard task of finding new and effective antibiotics.

CO-ADD tests compounds against five of the top pathogens listed on the WHO priority list for R&D of new antibiotics: Escherichia coli, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Staphylococcus aureus, as well as the fungi Cryptococcus neoformans and Candida albicans.

“We welcome the published list of priority pathogens to be worked on from the World Health Organization. Our research targets five of the pathogens listed, including the three most critical. This will be a vital tool that will guide antibiotic research and drug discovery for the future,” said CO-ADD Dr Mark Blaskovich.

CO-ADD media enquiries: r.neale1@uq.edu.au; +61 (0) 733462389

Radio National's Big Ideas programme on the antibiotic crisis featuring CO-ADD Dr Mark Blaskovich and Bond University Prof Chris Del Mar.

Our program coordinator for outreach Mathilde Desselle explains the idea and process behind CO-ADD’s open-access antimicrobial drug discovery program in a TEDxYouth talk.

Media release for the Chinese chemical community on the Community for Open Antimicrobial Drug Discovery